Mesenchymal stem cell therapy for severe emphysema

Pieter S. Hiemstra (Leiden, Netherlands)

Source: ERS Lung Science Conference 2021
Number: 30
Disease area: Airway diseases

WebcastSlide presentationPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Pieter S. Hiemstra (Leiden, Netherlands). Mesenchymal stem cell therapy for severe emphysema. ERS Lung Science Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Mesenchymal stem cells and fibrotic lung diseases
Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Year: 2014

Mesenchymal stem cells in aging and IPF
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016

Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017

Mesenchymal lineage formation in the lung during development and disease
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017

Mesenchymal stem cells and their potential for clinical use
Source: Annual Congress 2004 - Cellular and molecular strategies to repair the damaged lung
Year: 2004

Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009

Mesenchymal cells, immune cells and the lung stem cell niche
Source: Eur Respir Monogr 2021; 91: 134-143
Year: 2021

Noninfectious pulmonary complications of haematopoietic stem cell transplantation
Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019
Year: 2020

Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
Source: Eur Respir J 2005; 25: 402-405
Year: 2005

PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021

Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in mice
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008

Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury
Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020
Year: 2022

Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021

Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010

Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020

Mesenchymal stem cells and recombinant erythropoietin treatment in an experimental sepsis model
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012

Late Breaking Abstract - Mesenchymal stromal cells as a salvage treatment for persistent ARDS
Source: Virtual Congress 2020 – New insights into mechanical ventilation in the intensive care unit
Year: 2020

Pulmonary interstitial glycogenosis cells express mesenchymal stem cell markers
Source: Eur Respir J, 56 (4) 2000853; 10.1183/13993003.00853-2020
Year: 2020